4.5 Article

Software-based quantification of contrast-enhanced ultrasound in focal liver lesions-A feasibility study

期刊

EUROPEAN JOURNAL OF RADIOLOGY
卷 75, 期 2, 页码 E22-E26

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ejrad.2009.11.004

关键词

Liver lesion; Quantification; Contrast agent; Ultrasound; Software

资金

  1. ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung)

向作者/读者索取更多资源

Purpose: To compare software-based quantification of contrast-enhanced ultrasound (CEUS) examinations of focal liver lesions in the arterial and late phases with the enhancement patterns established by the sonologist. Materials and methods: The study cohort comprised 12 malignant and 21 benign hepatic lesions in 33 patients (18 female and 15 male; aged 57 +/- 13 years). All underwent dynamic real-time low mechanical index (<0.3) CEUS, which was stored as video sequences of the various enhancement phases. A software was used for analysis by using different regions of interest (ROI) in a double-blinded manner. The software generated and the visual enhancement patterns were compared, and the t-test was performed. Results: The videos containing the arterial phase had a mean length of 37.5 +/- 36.7 s and the late phase sequences a mean length of 15.2 +/- 9.2 s. In the arterial phase complete agreement between software and sonologist was 100%, 93.9% and 87.9% with regard to the entire lesion, its centre and its periphery, respectively. The late phase analysis revealed corresponding figures of 90.9%, 87.9% and 90.9%. In the late phase, benign lesions revealed a mean relative enhancement of +65.1 +/- 103.6% and malignant lesions -56.9 +/- 26.3% (p = 0.0005) vis-a-vis liver parenchyma. All the malignant and 14% of the benign tumors showed hypo-enhancement of less than-10%. Conclusion: The complete agreement between the quantitative analysis and the sonologist within the arterial and late phase showed excellent results. Software analysis of the late phase could dichotomise benign and malignant lesions. Objective establishment of iso-enhancement in the late phase excludes malignancy. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据